Results     28-May-14
Announcements
Indoco Remedies net profit rises 44.36% in the March 2014 quarter
Sales rise 15.82% to Rs 185.86 crore
Net profit of Indoco Remedies rose 44.36% to Rs 18.55 crore in the quarter ended March 2014 as against Rs 12.85 crore during the previous quarter ended March 2013. Sales rose 15.82% to Rs 185.86 crore in the quarter ended March 2014 as against Rs 160.48 crore during the previous quarter ended March 2013.

For the full year,net profit rose 35.72% to Rs 57.90 crore in the year ended March 2014 as against Rs 42.66 crore during the previous year ended March 2013. Sales rose 14.52% to Rs 717.37 crore in the year ended March 2014 as against Rs 626.43 crore during the previous year ended March 2013.

ParticularsQuarter EndedYear Ended
 Mar. 2014Mar. 2013% Var.Mar. 2014Mar. 2013% Var.
Sales185.86160.48 16 717.37626.43 15
OPM %17.6815.66 -16.7414.76 -
PBDT30.4320.51 48 103.0272.09 43
PBT22.5814.26 58 72.1148.37 49
NP18.5512.85 44 57.9042.66 36

Previous News
  Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets
 ( Corporate News - 04-Oct-24   14:26 )
  Indoco Remedies AGM scheduled
 ( Corporate News - 31-Aug-24   16:28 )
  Indoco Remedies fixes record date for final dividend
 ( Market Beat - Reports 30-Aug-24   14:57 )
  Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
 ( Corporate News - 21-Aug-24   19:58 )
  Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets
 ( Hot Pursuit - 21-Aug-24   13:12 )
  Indoco Remedies consolidated net profit declines 89.26% in the June 2024 quarter
 ( Results - Announcements 23-Jul-24   12:52 )
  Indoco Remedies to conduct board meeting
 ( Corporate News - 11-Jul-24   09:31 )
  Indoco Remedies receives USFDA approval for Canagliflozin and Metformin Hydrochloride Tablets
 ( Corporate News - 07-Jun-24   08:40 )
  Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug
 ( Hot Pursuit - 06-Jun-24   14:47 )
  Indoco Remedies' APIL Kilo Lab manufacturing unit completes USFDA audit
 ( Corporate News - 17-May-24   10:43 )
  US FDA concludes audit of Indoco's Rabale facility & IAS division with zero observations
 ( Hot Pursuit - 17-May-24   09:21 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top